TRAVASOL 8.5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Travasol 8.5% In Plastic Container patents expire, and when can generic versions of Travasol 8.5% In Plastic Container launch?
Travasol 8.5% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in two NDAs.
The generic ingredient in TRAVASOL 8.5% IN PLASTIC CONTAINER is amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRAVASOL 8.5% IN PLASTIC CONTAINER?
- What are the global sales for TRAVASOL 8.5% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for TRAVASOL 8.5% IN PLASTIC CONTAINER?
Summary for TRAVASOL 8.5% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 2 |
| DailyMed Link: | TRAVASOL 8.5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for TRAVASOL 8.5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 4 |
| McGill University Health Center | Phase 4 |
| Canadian Institutes of Health Research (CIHR) | Phase 4 |
Pharmacology for TRAVASOL 8.5% IN PLASTIC CONTAINER
| Drug Class | Amino Acid |
US Patents and Regulatory Information for TRAVASOL 8.5% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | TRAVASOL 8.5% IN PLASTIC CONTAINER | amino acids | INJECTABLE;INJECTION | 018931-002 | Aug 23, 1984 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Baxter Hlthcare | TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER | amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride | INJECTABLE;INJECTION | 020173-002 | Oct 27, 1995 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
